6.33
Lifemd Inc stock is traded at $6.33, with a volume of 1.57M.
It is up +0.64% in the last 24 hours and down -38.90% over the past month.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
See More
Previous Close:
$6.29
Open:
$6.25
24h Volume:
1.57M
Relative Volume:
0.80
Market Cap:
$300.15M
Revenue:
$193.06M
Net Income/Loss:
$-22.51M
P/E Ratio:
-9.8906
EPS:
-0.64
Net Cash Flow:
$10.63M
1W Performance:
-1.56%
1M Performance:
-38.90%
6M Performance:
+15.93%
1Y Performance:
+25.10%
Lifemd Inc Stock (LFMD) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
(866) 351-5907
Address
236 FIFTH AVENUE, NEW YORK
Compare LFMD with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
LFMD
Lifemd Inc
|
6.33 | 308.92M | 193.06M | -22.51M | 10.63M | -0.64 |
![]()
VEEV
Veeva Systems Inc
|
290.86 | 46.10B | 2.86B | 780.66M | 1.19B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
80.52 | 13.63B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
67.74 | 12.35B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
89.82 | 7.74B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
36.24 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-18-25 | Reiterated | BTIG Research | Buy |
Dec-10-24 | Initiated | Lake Street | Buy |
Dec-04-24 | Initiated | Mizuho | Neutral |
Aug-23-24 | Resumed | B. Riley Securities | Buy |
Jun-05-24 | Initiated | KeyBanc Capital Markets | Overweight |
Nov-30-23 | Initiated | Craig Hallum | Buy |
Jul-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Jul-03-23 | Initiated | H.C. Wainwright | Buy |
Mar-10-22 | Initiated | Colliers Securities | Buy |
Oct-04-21 | Resumed | B. Riley Securities | Buy |
View All
Lifemd Inc Stock (LFMD) Latest News
LifeMD rises as KeyBanc says telehealth revenue increasing - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against LifeMD, Inc. (LFMD) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Chart based exit strategy for LifeMD Inc.Earnings Growth Report & Growth Focused Stock Pick Reports - Newser
Has LifeMD Inc. found a price floorQuarterly Market Review & Weekly Top Gainers Trade List - Newser
Trend analysis for LifeMD Inc. this weekTrend Reversal & Reliable Entry Point Alerts - Newser
Using data filters to optimize entry into LifeMD Inc.2025 Winners & Losers & Capital Efficiency Focused Ideas - Newser
Risk vs reward if holding onto LifeMD Inc.Index Update & Free Low Drawdown Momentum Trade Ideas - Newser
Tick level data insight on LifeMD Inc. volatility2025 Analyst Calls & Precise Buy Zone Tips - Newser
Statistical indicators supporting LifeMD Inc.’s strength2025 Bull vs Bear & Technical Pattern Based Buy Signals - Newser
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against LifeMD, Inc. (LFMD) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Hims & Hers Fuels Growth via Market Expansion and New Care Verticals - TradingView
Combining machine learning predictions for LifeMD Inc.Market Trend Summary & Reliable Momentum Entry Alerts - Newser
LifeMD's Path to Profitability: Is the Dip in Share Price a Strategic Entry Point? - AInvest
LifeMD: The Dip Could Deepen, Valuation More Attractive (NASDAQ:LFMD) - Seeking Alpha
Is LifeMD Inc. stock reversal real or fakeJuly 2025 Snapshot & Daily Profit Focused Screening - Newser
Should you wait for a breakout in LifeMD Inc.2025 Dividend Review & Free Real-Time Market Sentiment Alerts - Newser
Chart based analysis of LifeMD Inc. trends2025 Breakouts & Breakdowns & Technical Pattern Based Signals - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages LifeMD, Inc. (LFMD) Investors to Inquire about Securities Investigation - ACCESS Newswire
Applying big data sentiment scoring on LifeMD Inc.July 2025 Rallies & High Yield Stock Recommendations - Newser
Market Accountability and Investor Risk Mitigation in the Telehealth Sector: Lessons from LifeMD's Q2 2025 Earnings Shock - AInvest
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against LifeMD, Inc. (LFMD) And Encourages Investors to Reach Out - ACCESS Newswire
Investor Alert: LifeMD, Inc. Faces Securities Class Action Investigation - AInvest
Visual analytics tools that track LifeMD Inc. performance2025 Historical Comparison & Accurate Intraday Trade Tips - Newser
Is LifeMD Inc. benefiting from innovation trends2025 Investor Takeaways & Capital Efficient Trade Techniques - thegnnews.com
Volume Profile Shows Strong Base for LifeMD Inc.Quarterly Trade Report & Verified Short-Term Plans - beatles.ru
Earnings visualization tools for LifeMD Inc.July 2025 Earnings & Reliable Trade Execution Plans - Newser
LifeMD Investigation: Schall Law Firm Examines Securities Violations - AInvest
LFMD Investors Have Opportunity to Join LifeMD, Inc. Fraud Investigation with the Schall Law Firm - The Globe and Mail
LFMD Investor News: If You Have Suffered Losses in LifeMD, - GlobeNewswire
LifeMD Investigation Over Alleged Misleading Business Information - AInvest
מידע למשקיעי LFMD: אם סבלתם מהפסדים ב- LifeMD, Inc. (נאסד"ק: LFMD), אתם מוזמנים ליצור קשר עם משרד רוזן עורכי דין לגבי זכויותיכם - GlobeNewswire Inc.
Using Ichimoku Cloud for LifeMD Inc. technicalsPortfolio Gains Summary & Breakout Confirmation Alerts - Newser
Buy Signal for LifeMD Inc. Stock Key Technical Indicators to WatchJuly 2025 Selloffs & Expert-Curated Trade Recommendations - Newser
Price action breakdown for LifeMD Inc.2025 Market Outlook & Weekly High Momentum Picks - Newser
LFMD Investor News: Rosen Law Firm Encourages LifeMD, Inc. Investors to Inquire About Securities Class Action InvestigationLFMD - Eastern Progress
Investor Alert: LifeMD, Inc. Securities Class Action Investigation - AInvest
LifeMD shares fall 1.15% intraday after Rosen Law Firm announces investigation into potential securities claims. - AInvest
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against LifeMD, Inc. (LFMD) And Encourages Stockholders to Reach Out - ACCESS Newswire
LifeMD, Inc. (NASDAQ:LFMD) Shares Sold by XTX Topco Ltd - Defense World
What is the earnings history of LifeMD Inc.Chart Signals & Weekly Top Gainers Alerts - sundaytimes.kr
Insider Spends US$501k Buying More Shares In LifeMD - 富途牛牛
LifeMD, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating LifeMD, Inc. (LFMD) And Encourages Stockholders to Connect - ACCESS Newswire
Securities Litigation and Shareholder Turmoil at LifeMD: A Case Study in Corporate Transparency and Market Reactions - AInvest
Investigation into Potential Securities Claims against LifeMD, Inc. - AInvest
LifeMD shares fall 2.47% premarket after Rosen Law Firm announces investigation into potential securities claims. - AInvest
LifeMD Inc. Shows Support at Fibonacci LevelQuarterly Trade Review & Comprehensive Market Scan Reports - beatles.ru
LifeMD Investors Encouraged to Inquire About Securities Class Action Investigation - AInvest
Rosen Law Firm Encourages LifeMD, Inc. Investors to Inquire About Securities Class Action Investigation – LFMD - The Joplin Globe
Lifemd Inc Stock (LFMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):